Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 41.00
Ask: 42.00
Change: -2.00 (-4.60%)
Spread: 1.00 (2.439%)
Open: 43.50
High: 43.50
Low: 41.50
Prev. Close: 43.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio news – Pulsiv appoints Chairman and CPO

11 Sep 2023 07:00

RNS Number : 9325L
Frontier IP Group plc
11 September 2023
 

Reach - a non-regulatory announcement

AIM: FIPP

11 September 2023

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Pulsiv appoints Dr Mark Gerhard as Chairman and Dr Tim Moore as Chief Product Officer

 

Frontier IP, a specialist in commercialising intellectual property, today welcomes the following announcement from portfolio company Pulsiv Limited (the "Company" or "Pulsiv") of the appointments of Dr Mark Gerhard as Chairman and Dr Tim Moore as Chief Product Officer. Both will be members of the Company's Board of Directors.

 

Mark is a serial entrepreneur and technology pioneer with a long history of growing and exiting businesses in the video games, artificial intelligence ("AI") and cyber-security sectors. They include Jagex, the developer of the Runescape online game, which was sold for $250 million in 2010 when Mark was Chief Executive Officer.

 

He is currently chairman of MarketWise, a Nasdaq-listed provider of investment research and investor services, co-founder and Chief Executive Officer of AI software and computer games developer PlayFusion, and founder of investment firm Cambridge Ventures.

 

Tim is joining the Company full time from his role as Chief Technology Officer for SharkNinja, a Nasdaq-listed consumer electronics group. He has extensive experience in developing innovative products, taking them from invention to launch. Tim was previously Chief Technology Officer of multinational consumer technology brand ghd.

 

Frontier IP holds an 18.2 per cent equity stake in Pulsiv.

 

Neil Crabb, Frontier IP Chief Executive Officer, said: "I am delighted to welcome Mark and Tim (full time) to the Pulsiv Board of Directors. Pulsiv has now developed a global distribution network and has attracted significant industry interest, including a collaboration with Salom, a major manufacturer of power supplies. Mark and Tim's long and successful history of building businesses and products will prove invaluable as Pulsiv now enters an exciting stage of its journey to become a significant green technology business."

 

Pulsiv statement begins:

 

Appointment of Dr Mark Gerhard as Chairman and Dr Tim Moore as Chief Product Officer

 

Cambridge 11 September 2023

 

Pulsiv, the Cambridge-based deep tech start-up set to revolutionise power conversion and renewable energy generation, is pleased to announce the appointments of Dr Mark Gerhard as Chairman and Dr Tim Moore as Chief Product Officer.

· Mark is a serial entrepreneur and technology pioneer who has successfully grown and exited businesses in the video games, artificial intelligence and cyber-security sectors.

· Previously a Pulsiv non-executive director, Tim is joining the company full-time having recently served as Chief Technology Officer for SharkNinja, a NYSE-listed consumer electronics group.

 

Dr Mark Gerhard

 

Mark was the Chief Technology Officer and then Chief Executive Officer of Jagex, one of the UK's largest independent games developers and publishers, which he grew from a single product company to one with multiple games running on multiple platforms. Jagex was sold for $250 million in 2010 while Mark was CEO. He co-founded and was CEO and CTO of Beauty Labs International, a developer of AI tools for the beauty industry which was sold to US biotech Amyris Inc in 2021 for a nine-figure sum, and was CEO of Ascendant Digital Acquisition Corp, a special purpose acquisition company. Ascendant Digital merged with Beacon Street Group, a company providing investment research and other investor services, in a deal worth $3 billion. The combined entity, called MarketWise, is listed on Nasdaq. Mark now chairs the company.

 

His other current roles include founder and CEO of PlayFusion and founder of investment firm Cambridge Venture Partners. PlayFusion is an independent games developer and publisher, which is creating a next-generation artificial intelligence platform and immersive game and TV show. He is Vice-chair of TIGA, the UK trade body for video games developers and publishers and serves as a board member and director of UK games developer Build A Rocket Boy.

 

Dr Tim Moore

 

Tim has a proven record of developing and releasing innovative products from invention through to global launch. He has worked in China, Europe and the US for start-ups, private equity backed companies and major corporates. Having recently held executive roles with multinational consumer technology brands such as ghd and SharkNinja, he brings extensive industry knowledge to Pulsiv. He has driven considerable value in M&A and transactions, selling to both private equity and industry participants. While he was Chief Technology Officer of ghd, Tim was a key team member in three sales of the Jemella Group, owner of ghd, over a 10-year period.

 

 

 

"I'm delighted to welcome Mark at such an important stage in our journey. His vision, experience and drive will help Pulsiv to capitalise on our progress to date and achieve global ambitions. It's also a huge vote of confidence that Tim has chosen to take a full-time role. He has been a valuable member of our Board and will heavily influence the evolution of Pulsiv's product portfolio. We have an opportunity to cut the energy consumed by billions of devices and harness more solar power than existing solutions. Company values and culture are very important to Pulsiv, so anyone who knows Mark or Tim will recognise that they're a great fit."

 

Pulsiv CEO Darrel Kingham

 

"Pulsiv has all the technology and talent to become a global leader in power conversion technology. With 52 fundamental granted patents and a further 31 patents pending, Pulsiv is perfectly placed to be disruptive and offer something new to the power electronics industry. Their simple business model coupled with their deep IP portfolio and an experienced management team is highly analogous to ARM computing for power conversion. I am honoured and privileged to join the team as Chairman at this very exciting time for the company."

 

Pulsiv Chairman Dr Mark Gerhard

 

"I have been involved with Pulsiv since 2021 and have seen the excellent progress that the company has made since then. Its technology has the potential to be highly disruptive across a very broad range of applications. Pulsiv OSMIUM can improve the efficiency of electricity conversion in a cost-effective way by using readily available electronic components. What is so exciting is that the technology is ready now to reduce bills for consumers and rapidly drive the much-needed decarbonisation of our economy. I am thrilled to have the chance to join full time and use my experience to drive positive impact in the green economy."

 

Pulsiv Chief Product Officer Dr Tim Moore

 

 

 

Pulsiv statement ends

 

 

 

ENQUIRIES

 

 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

 

T: 0203 328 5656

 

 

 

ABOUt pulsiv

Based in Cambridge, UK, Pulsiv has developed and patented innovative technology to intelligently manage power wherever it is converted. Pulsiv OSMIUM products are designed to improve efficiency, optimise cost and reduce overall energy consumption in billions of electrical devices that are powered or charged from a mains supply. In addition, Pulsiv Horizon provides a unique power architecture for extracting the maximum energy from photovoltaic panels to increase the total output from future solar installations.

 

Pulsiv is committed to helping the world move towards 100% renewable energy and reducing the long-term environmental impact of all electronic devices. Find out more at https://www.pulsiv.co.uk/

ABout frontier IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABDGDCLBBDGXG
Date   Source Headline
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project
30th Nov 20225:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.